Monitor warrant exercise activity and potential share dilution. The company's small market cap ($22M) and history of capital raising suggest ongoing funding needs. Watch for financial results in the incorporated 2025 Annual Report on Form 20-F.
Executive Summary
IceCure Medical Ltd. is registering up to 16 million ordinary shares for resale by selling shareholders, consisting of shares issuable upon exercise of Series B and Series C warrants issued in a March 2026 offering. The company will not receive proceeds from the resale but will receive $8.8 million if all warrants are exercised. This filing follows recent effectiveness notices for shelf and primary registration statements, indicating ongoing capital raising efforts.
Key Facts
- Filing is for resale of up to 16 million ordinary shares by selling shareholders from warrants issued in March 2026 offering
- Company will not receive proceeds from resale but will receive $8.8 million if all warrants are exercised at $0.55 per share
- Follows recent effectiveness notices for shelf and primary registration statements indicating ongoing capital raising
- Company is an Israeli medical device firm focused on cryoablation systems for tumor treatment
- No financial results disclosed in this F-1 filing; references incorporated 2025 Annual Report on Form 20-F
Financial Impact
Up to $8.8 million in potential proceeds if all warrants are exercised
Risk Factors
- Significant dilution risk from warrant exercises and potential future offerings
- Low trading volume and small market cap increase volatility risk
- Judgment enforcement challenges due to Israeli incorporation and international directors
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1 Filing (Primary) | 0001213900-26-038556 |
| Document: ea028441101ex-fee.htm | 0001213900-26-038556 |
| Document: ea028441101ex5-1.htm | 0001213900-26-038556 |
| Document: ea028441101ex23-1.htm | 0001213900-26-038556 |
| Document: 0001213900-26-038556-index-headers.html | 0001213900-26-038556 |
| Document: 0001213900-26-038556-index.html | 0001213900-26-038556 |
| Document: 0001213900-26-038556.txt | 0001213900-26-038556 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.10 | awaiting T+60 | — | $1.03 (−6.36%) |
Oct 5, 2026 21d ago | 6-K | $1.27 | awaiting T+60 | — | $1.03 (−18.90%) |
Oct 5, 2026 21d ago | 6-K | $1.54 | awaiting T+60 | — | $1.03 (+33.12%) |
Sep 10, 2026 6w ago | 6-K | $2.14 | awaiting T+60 | — | $1.03 (−51.87%) |
Aug 24, 2026 9w ago | 6-K | $2.27 | awaiting T+60 | — | $1.03 (−54.63%) |
Aug 19, 2026 9w ago | EFFECT | $2.52 | awaiting T+60 | — | $1.03 (+59.13%) |
Aug 14, 2026 10w ago | 6-K | $2.82 | awaiting T+60 | — | $1.03 (−63.48%) |
Aug 12, 2026 10w ago | 6-K | $3.11 | awaiting T+60 | — | $1.03 (−66.83%) |
Jul 6, 2026 16w ago | EFFECT | $4.61 $1.59 | ▲ +65.51% | ▲ +67.23% | $1.03 (+77.66%) |
Jun 26, 2026 17w ago | 6-K | $5.26 $1.95 | ▲ +62.93% | ▲ +67.31% | $1.03 (+80.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers